Sign In
Buy DXCM
$86.94
-0.370 (-0.424%)
At Close: Aug 04, 2026
Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders
06:30pm, Wednesday, 09'th Jul 2025
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (
2 Stocks to Buy on the Dip and Hold for 10 Years
09:45am, Sunday, 06'th Jul 2025
One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but still
Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year?
10:41am, Thursday, 03'rd Jul 2025
Here is how DexCom (DXCM) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
3 Reasons Growth Investors Will Love DexCom (DXCM)
01:46pm, Wednesday, 02'nd Jul 2025
DexCom (DXCM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
12:20pm, Tuesday, 01'st Jul 2025
Shares of Dexcom, Tandem Diabetes and Insulet skidded Tuesday on a proposal that would cut Medicare reimbursements for wearable diabetes tech.
Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.
08:30am, Tuesday, 01'st Jul 2025
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Management wil
Here's Why DexCom (DXCM) is a Strong Momentum Stock
10:55am, Friday, 27'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
10:50am, Wednesday, 25'th Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DXCM's Access Gains and Operational Strength Offset Margin Pressures
10:26am, Friday, 20'th Jun 2025
DXCM rides on record patient growth and T2D access gains, but margin pressure and FDA scrutiny cloud the outlook.
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
08:30am, Wednesday, 18'th Jun 2025
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th S
Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders
02:06pm, Tuesday, 10'th Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for
Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders
01:21pm, Thursday, 05'th Jun 2025
SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (
Jefferies' high conviction US stocks for the summer: Nvidia among top picks
01:36pm, Wednesday, 04'th Jun 2025
Global brokerage firm Jefferies shared their top 28 US stocks in the “highest-conviction Buy rated” stocks. Jefferies shared the list as the US market is coming fresh off its best month in May sin
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
11:35am, Wednesday, 04'th Jun 2025
BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.
Prediction: These 2 Stocks Will Beat the Market in the Next Decade
03:46am, Tuesday, 27'th May 2025
Investors typically want to beat the market over the long run. Though it's not an easy task, it certainly is possible with the right companies.
